Cytosorb, an extracorporeal blood purification system, utilises the principles of haemoadsorption to remove low molecular weight substances from the blood, including multiple cytokines such as interleukin (IL)-1b, IL-6, IL-8, and tumour necrosis factor-α,
Raja, Shahzad G. +6 more
core
International registry on the use of the CytoSorb® adsorber in ICU patients
INTRODUCTION: The aim of this clinical registry is to record the use of CytoSorb(R) adsorber device in critically ill patients under real-life conditions. METHODS: The registry records all relevant information in the course of product use, e.
Z. Molnar +52 more
core +1 more source
Drowning remains a significant global health concern, claiming over 300,000 lives annually, with a disproportionate impact on young individuals in low-and middle-income countries.
Pedja Kovacevic +13 more
doaj +1 more source
2025 ACVIM Forum Research Abstract Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source
Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment
We describe the use of Cytosorb™, a synthetic extracorporeal haemoperfusion adsorption column, in the management of two patients with drug induced cholestasis and a third with alcoholic hepatitis and subsequent acute on chronic liver failure.
VD Dhokia +3 more
core +1 more source
The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis. [PDF]
Gräfe C +9 more
europepmc +1 more source
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure. [PDF]
Liebchen U +5 more
europepmc +1 more source
Background: Septic shock with acute kidney injury is associated with high mortality. Hemoadsorption methods such as CytoSorb® in conjunction with standard continuous renal replacement therapy (CRRT) and oXiris®-based CRRT are increasingly used ...
Spirić, Nikolina +8 more
core +1 more source
The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock. [PDF]
Ferrer R +24 more
europepmc +1 more source
The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients. [PDF]
Ferrer R +28 more
europepmc +1 more source

